condyline
takeda pharmaceuticals australia pty ltd - podophyllotoxin -
condyline 0.5 % w/v cutaneous solution
nycomed danmark aps - podophyllotoxin - cutaneous solution - 0.5% %w/v
condyline paint
takeda pharmaceuticals australia pty ltd - podophyllotoxin -
eposin, concentrate for solution for infusion 20mg/ml
pharmachemie b.v. - etoposide, ph.eur. - concentrate for solution for infusion (to dilute). - 20mg/ml - podophyllotoxine derivatives - for the management of: - testicular tumours in combination with other chemotherapeutic agents - small cell lung cancer, in combination with other chemotherapeutic agents - monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard therapy has failed (in combination with other chemotherapeutic agents).
etoposide 100mg/5ml concentrate for solution for infusion vials
actavis uk ltd - etoposide - solution for infusion - 20mg/1ml
condylox 5mg/ml solution for use on the skin
focused pharma ltd 37, geronimo abos street, iklin ikl 1022, malta - solution - podophyllotoxin 5 mg/ml - antibiotics and chemotherapeutics for dermatological use
warticon 0.15% w/w cream
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - cream - podophyllotoxin 1.5 mg/g - antibiotics and chemotherapeutics for dermatological use
warticon cream 0.15 %w/w
eurodrug ltd - podophyllotoxin - cream - 0.15 %w/w
condyline 3.5ml sol
elder - podophyllotoxin - sol - 5mg/ml - 3.5ml
wartec cream 0.15% w/w
glaxosmithkline pte ltd - podophyllotoxin - cream - 0.15% w/w